NRx Pharmaceuticals, Inc.
NRXP
$3.28
$0.072.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 440.33% | 336.45% | 53.32% | 320.62% | -68.60% |
| Total Receivables | -- | 55,333.33% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -43.00% | -10.52% | -57.18% | -5.23% | -26.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -58.25% | -- | -8.31% | -27.13% | -5.40% |
| Total Current Assets | 169.29% | 190.96% | -5.94% | 116.79% | -52.03% |
|
|
|||||
| Total Current Assets | 169.29% | 190.96% | -5.94% | 116.79% | -52.03% |
| Net Property, Plant & Equipment | 6,860.00% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.37% | -31.74% | -37.50% | -24.26% | -21.35% |
| Total Assets | 254.86% | 236.08% | -8.09% | 100.37% | -50.09% |
|
|
|||||
| Total Accounts Payable | 3.39% | -12.52% | -27.62% | -31.19% | -10.84% |
| Total Accrued Expenses | 0.75% | -5.10% | -16.31% | -5.37% | 17.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -74.64% | 231.08% | 28.79% | 23.87% | -86.40% |
| Total Finance Division Other Current Liabilities | 72.04% | 213.83% | 447.24% | 55,926.92% | 60,805.88% |
| Total Other Current Liabilities | 72.04% | 213.83% | 447.24% | 55,926.92% | 60,805.88% |
| Total Current Liabilities | 30.71% | 99.98% | 71.01% | 73.68% | 14.78% |
|
|
|||||
| Total Current Liabilities | 30.71% | 99.98% | 71.01% | 73.68% | 14.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.51% | 75.02% | 71.01% | 73.68% | 41.09% |
|
|
|||||
| Common Stock & APIC | 14.08% | 12.43% | 6.65% | 5.73% | 5.65% |
| Retained Earnings | -10.29% | -14.14% | -12.63% | -9.28% | -9.93% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 31.37% | -36.83% | -93.65% | -66.97% | -97.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.37% | -36.83% | -93.65% | -66.97% | -97.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.37% | -36.83% | -93.65% | -66.97% | -97.93% |
|
|
|||||